SLC15A2 and chronic myelogenous leukemia, BCR-ABL1 positive: Intriguingly, prior to IM therapy, SLC15A2 mRNA levels were indeed higher in BM leukaemia cells of nine CML patients than in the BM haematopoietic cells of nine healthy individuals (Fig. 6a).